483 Fresenius Kabi USA Jan 2013

483 Fresenius Kabi USA Jan 2013

James Bridges FDA, Kevin Gonzalez FDA, Karen Kosar FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi USA - Grand Island, NY, United States facility and issued 8 inspectional observations (via FDA 483) on 11 Jan 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 8
  • Inspection end: 11 Jan 2013
  • Location: Grand Island, United States
  • FEI: 3001833549
Add To Cart